genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
Gene Therapy
Shooting the Messenger: Locana Bio Writes a New Script for RNA…
News
Gene Therapy
Paralyzed Mice Walk Again after Treatment with Designer Cytokine
Drug Discovery
New Antimicrobial Streptomyces Species Discovered in Ancient Irish Soil
Cancer
Circadian Rhythm Target Identified for Prostate Cancer
News
Why Antihistamines Often Don’t Work to Control Severe Itch
Genetics
Potential Pathway for Rare Neurological Disorder Discovered
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
Bioprocessing
New Promise for Spinal-Cord Injuries
Drug Discovery
Trojan Horse Antidotes Designed to Neutralize Lethal Botulinum Toxin
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Gene Therapy
Paralyzed Mice Walk Again after Treatment with Designer Cytokine
Drug Discovery
New Antimicrobial Streptomyces Species Discovered in Ancient Irish Soil
Cancer
Circadian Rhythm Target Identified for Prostate Cancer
Bioprocessing
Major Expansions Planned for Cobra Biologics and Cognate BioServices
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
RNA
RNAi
Page 3
RNAi
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
RNAi
Lilly, Dicerna Launch $3.7B+ RNAi Collaboration
RNAi
Alexion, Dicerna Launch $637M+ RNAi Collaboration in Complement-Mediated Diseases
RNAi
Autism Genetic Complexity Comes to Light
RNAi
RNA Editing Website
RNAi
RXi Partners with University of Massachusetts Med School on RNAi Therapeutics for Ocular Disease
RNAi
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
RNAi
RNAi TECHNOLOGY
RNAi
Chemokine Receptor-Targeting siRNA Nanoparticles Used to Reduce Damage in Multiple Disease...
RNAi
CRISPR Screen IDs Human Host Genes for HIV
RNAi
RNA Drugs Can Escape Endosomal Confinement, Tumor Spheroids Confirm
RNAi
Ipsen and Dicerna to Develop Gene-Silencing Therapeutics for Cancer and Endocrinology
RNAi
Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification
RNAi
MicroRNA Maneuvers Limit Time on Target, Maintain Ace Status
RNAi
Sirnaomics Wins SBIR Award to Develop Wound-Healing Product
RNAi
RNAi Shares Discovery Spotlight with CRISPR-Cas
1
2
3
4
...
6
Page 3 of 6
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Illustration of chromosome 16 showing the 14 fly counterparts of the 25 human genes located in a deletion on the chromosome that is associated with autism risk. Researchers used RNA interference (RNAi) to the reduce the expression of these genes individually and in tandem to test how the interactions of these genes modulate neurodevelopmental symptoms associated with the deletion. Interactions between genes that either enhance or suppress the affect of reduced expression are shown by red or blue lines. [Girirajan Laboratory/Penn State]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul2_2018_PennState_Chromosome16Ilustration4113701011-265x198.jpg "Autism Genetic Complexity Comes to Light")
